Month: July 2024
A new report analyzed dietary eating patterns among more than 100,000 people over the course of 30 years.
The US Supreme Court has again overturned longstanding precedent, this time getting rid of a 40-year- old standard for decision making that required federal courts to defer to reasonable agency decisions where federal law is silent or unclear.
Recent Supreme Court decisions curbing the power of federal agencies will hobble government efforts to protect public health, legal experts warn. The rulings will make it harder for some federal agencies to bring enforcement actions.
As Americans tuned into the presidential debate last Thursday, critical issues like Social Security and Medicare came up. These programs act as lifelines for millions of Americans, especially seniors who have historically been a strong voting block.
A report from a conservative think tank found that as many as 5 million people are wrongfully receiving Affordable Care Act insurance subsidies, prompting House Republican leaders to call for an investigation into possible enrollment fraud.
In your work with employers, it’s important to discuss the substantial tax advantages available to businesses when they offer health insurance benefits to employees. Not only can these benefits help attract and retain top talent, but they also provide significant financial incentives.
The health care industry put a measure on the November ballot that would raise more money for Medi-Cal and block lawmakers from spending it on general government services. Billions of dollars are on the line.
A provision of Biden’s Inflation Reduction Act requires drugmakers to pay rebates to Medicare if they hike the price of a medication faster than the rate of inflation.
Paying more for less is a recurring theme for Americans these past few years, and it’s even true in health care, a new study shows. Health insurers are covering fewer drugs, putting more restrictions on their drug coverage, but still raising costs for consumers, prescription drug comparison site GoodRx found after reviewing more than 3,700 Medicare Part ...
After the Supreme Court struck down a controversial bankruptcy plan from Purdue Pharma, the maker of OxyContin, those who sued the drug company were left uncertain about when promised funds would be available to combat addiction and other damage from the ongoing drug epidemic. The ruling upended a carefully-crafted settlement worth roughly $8 billion, and involving the Sackler family, ...